Semaglutide-Associated Ischemic Colitis in a Patient Without Traditional Risk Factors: A Case Report

This report describes the case of a 43-year-old female patient presenting with left lower quadrant pain and bloody diarrhea, initially managed as infectious colitis. Despite treatment, symptoms persisted, leading to repeat imaging showing mild pancolitis with colon mucosal hyperenhancement and wall thickening. Admission for intravenous hydration and subsequent colonoscopy revealed findings consistent with ischemic colitis. Semaglutide (Ozempic), which the patient had been taking, was discontinued, and symptoms resolved post discharge without semaglutide use for several months. This suggests a potential association between semaglutide and ischemic colitis in a patient without known risk factors. This case underscores the importance of considering medication-induced colitis in patients presenting with persistent gastrointestinal symptoms, particularly in the absence of typical risk factors.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-02-10
DOI
https://doi.org/10.7759/cureus.78832
Citations
2
Primary Topic
Potassium and Related Disorders
Type
article
Field-Weighted Citation Impact
3.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Semaglutide-Associated Ischemic Colitis in a Patient Without Traditional Risk Factors: A Case Report

Sommer Sekhon, John Bacon, Ibaadat Sukhmanii Kahlon
2 citations
Cureus
Potassium and Related Disorders
3.04
article

Semaglutide-Associated Ischemic Colitis in a Patient Without Traditional Risk Factors: A Case Report

Sommer Sekhon, John Bacon, Ibaadat Sukhmanii Kahlon
article en
2 citations

Abstract

This report describes the case of a 43-year-old female patient presenting with left lower quadrant pain and bloody diarrhea, initially managed as infectious colitis. Despite treatment, symptoms persisted, leading to repeat imaging showing mild pancolitis with colon mucosal hyperenhancement and wall thickening. Admission for intravenous hydration and subsequent colonoscopy revealed findings consistent with ischemic colitis. Semaglutide (Ozempic), which the patient had been taking, was discontinued, and symptoms resolved post discharge without semaglutide use for several months. This suggests a potential association between semaglutide and ischemic colitis in a patient without known risk factors. This case underscores the importance of considering medication-induced colitis in patients presenting with persistent gastrointestinal symptoms, particularly in the absence of typical risk factors.

CureusVol. 17(2)
University of Medicine and Health Sciences (KN), Saint Agnes Medical Center (US), California State University, Fresno (US)
Openalex Percentile: Top 11%
Potassium and Related Disorders
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.